NCT03795740

Brief Summary

This study is a effectiveness study of the application of high-definition enhanced computed-tomography for patients with chronic thromboembolic pulmonary hypertension(CTEPH).The patients with CTEPH was randomized into 2 groups,precise pulmonary endarterectomy group(guided by enhanced CT scanning) and traditional pulmonary endarterectomy group,the hemodynamic changes tested with right sided heart catherization from baseline to post-operative period and end-point including peri-operative deaths,follow-up mortality,follow-up parameters of ultrasonic cardiogram(UCG),right-sided heart catherization(RHC),nuclear magnetic resonance imaging(MRI),cardiac pulmonary exercise test(CPET) are documented,so as to compare the prognosis between these 2 groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

December 19, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 8, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

January 8, 2019

Status Verified

December 1, 2018

Enrollment Period

3.3 years

First QC Date

December 19, 2018

Last Update Submit

January 4, 2019

Conditions

Keywords

computed tomographychronic thromboembolic pulmonary hypertensionpulmonary endarterectomyresultrandomized controlled trial

Outcome Measures

Primary Outcomes (5)

  • Change from Baseline pulmonary systolic pressure within 1 month

    Systolic pulmonary pressure result tested by right-sided heart

    within 1 month before and after pulmonary endarterectomy surgery

  • Change from Baseline pulmonary mean pressure within 1 month

    Mean pulmonary pressure result tested by right-sided heart

    within 1 month before and after pulmonary endarterectomy surgery

  • Change from Baseline pulmonary vascular resistance within 1 month

    Pulmonary vascular resistance result tested by right-sided heart

    within 1 month before and after pulmonary endarterectomy surgery

  • Change from Baseline cardiac output within 1 month

    Cardiac output result tested by right-sided heart

    within 1 month before and after pulmonary endarterectomy surgery

  • mortality rate after surgery

    mortality rate after surgery

    immediately after the surgery to the longest 48 months follow-up period

Secondary Outcomes (8)

  • Follow-up right ventricular ejection fraction

    3-24 months after the surgeries

  • Follow-up tricuspid annular plane systolic excursion

    3-24 months after the surgeries

  • Follow-up right ventricular anterior-posterior diameter

    3-24 months after the surgeries

  • Follow-up tricuspid insufficiency level

    3-24 months after the surgeries

  • Follow-up peak oxygen consumption (Peak O2) result

    6-24 months after the surgeries

  • +3 more secondary outcomes

Study Arms (2)

Precise

EXPERIMENTAL

precise PEA therapy with the guide of 3-D imaging techniques

Diagnostic Test: 3-D CT scanning

Placebo

PLACEBO COMPARATOR

traditional PEA therapy solely by surgical probe and traditional CT scanning/pulmonary angiography method

Diagnostic Test: 3-D CT scanning

Interventions

3-D CT scanningDIAGNOSTIC_TEST

For patients in Group 1,precisely analyzed CT scanning and/or pulmonary angiography will be done,and the patients in Group 1 will receive PEA procedure with the guide of precise 3-D imaging techniques

PlaceboPrecise

Eligibility Criteria

AgeUp to 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Definite diagnosed with chronic thromboembolic pulmonary hypertension with the right-sided cathrization and pulmonary angiography;
  • The computed tomography imaging implied that the location of the embolism could be reached with surgeries;

You may not qualify if:

  • Beyond the age limit described above,or combined with other severe conditions such as severe organ dysfunction and considered contraindicated for surgical therapy by the cardiac surgeons;
  • Without the consent by the patient or his/her families;
  • Acute pulmonary embolism;
  • Pulmonary sarcoma;
  • Pulmonary arteritis;
  • Combined with cardiogenic pulmonary hypertension or idiopathic pulmonary hypertension;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai Hospital,Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, 100044, China

RECRUITING

Related Publications (7)

  • Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003 Nov;76(5):1457-62; discussion 1462-4. doi: 10.1016/s0003-4975(03)00828-2.

    PMID: 14602267BACKGROUND
  • Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004 May 27;350(22):2257-64. doi: 10.1056/NEJMoa032274.

    PMID: 15163775BACKGROUND
  • Coquoz N, Weilenmann D, Stolz D, Popov V, Azzola A, Fellrath JM, Stricker H, Pagnamenta A, Ott S, Ulrich S, Gyorik S, Pasquier J, Aubert JD. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur Respir J. 2018 Apr 4;51(4):1702505. doi: 10.1183/13993003.02505-2017. Print 2018 Apr.

    PMID: 29563171BACKGROUND
  • Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States. Curr Med Res Opin. 2011 Sep;27(9):1763-8. doi: 10.1185/03007995.2011.604310. Epub 2011 Jul 27.

    PMID: 21793646BACKGROUND
  • Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barbera JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jais X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry. Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.

    PMID: 26826181BACKGROUND
  • Inami T, Kataoka M, Ando M, Fukuda K, Yoshino H, Satoh T. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One. 2014 Apr 11;9(4):e94587. doi: 10.1371/journal.pone.0094587. eCollection 2014.

    PMID: 24728482BACKGROUND
  • Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barbera JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jais X, Simonneau G. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3.

    PMID: 21969018BACKGROUND

Related Links

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Adult Cardiac Surgery Center

Study Record Dates

First Submitted

December 19, 2018

First Posted

January 8, 2019

Study Start

February 1, 2017

Primary Completion

May 31, 2020

Study Completion

December 31, 2022

Last Updated

January 8, 2019

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

We have yet no plan to share IPD with other researchers

Locations